These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7933783)
1. [Antiaggregation therapy with ibustrin in patients with ischemic heart diseases]. Liusov VA; Diukov IV; Uteshev DB; Fomchenkov IV Kardiologiia; 1993; 33(4):17-9. PubMed ID: 7933783 [No Abstract] [Full Text] [Related]
2. [Effect of indobufen on leukocyte-dependent thrombocyte aggregation in patients with ischemic heart disease]. Liusov VA; Diukov IV; Uteshev DV Kardiologiia; 1993; 33(4):22-3. PubMed ID: 7933785 [No Abstract] [Full Text] [Related]
3. A comparative study between indobufen and acetylsalicylic acid on beta-thromboglobulin, platelet factor 4 and platelet aggregation in patients with transient ischemic attacks. Orefice G; Carrieri P; Indaco A; Iorillo L; Fioretti A Acta Neurol (Napoli); 1984 Apr; 6(2):97-103. PubMed ID: 6204513 [No Abstract] [Full Text] [Related]
4. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk]. Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826 [TBL] [Abstract][Full Text] [Related]
5. [The effect of indobufen on platelet function and dialyzer regeneration in patients on hemodialysis]. Sokołowska B; Dmoszyńska A; Janicka L; Walter-Croneck A Pol Arch Med Wewn; 1995 Jun; 93(6):475-82. PubMed ID: 7491347 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of morning platelet aggregation in patients with ischemic cardiopathy after evening administration of indobufen]. Craveri A; Lanfredini M; Citella C; Braconaro F; Colombo L Minerva Cardioangiol; 1988 Sep; 36(9):411-8. PubMed ID: 3226570 [No Abstract] [Full Text] [Related]
7. Beta-thromboglobulin and platelet factor 4 plasma levels during haemodialysis: effect of indobufen. Pogliani EM; Colombi M; Cristoforetti G; Valenti G; Miradoli R; Buccianti G Pharmatherapeutica; 1982; 3(2):127-32. PubMed ID: 6179101 [TBL] [Abstract][Full Text] [Related]
8. Reduction of plasma levels of betathromboglobulin and platelet factor 4 during hemodialysis: a possible role for a short acting inhibitor of platelet aggregation. Buccianti G; Pogliani E; Miradoli R; Colombi MA; Valenti G; Lorenz M; Polli EE Clin Nephrol; 1982 Oct; 18(4):204-8. PubMed ID: 6183040 [TBL] [Abstract][Full Text] [Related]
9. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients. Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671 [TBL] [Abstract][Full Text] [Related]
10. [Prevention of the recurrence of episodes of cerebral ischemia. Therapeutic protocol]. Mazzei B; Carelli A; Gaudio G; Stellato G; Cundari E; Corsonello F Minerva Med; 1988 Aug; 79(8):703-6. PubMed ID: 3405477 [No Abstract] [Full Text] [Related]
11. [Effect of a micellar preparation of polyunsaturated phosphatidylcholine on platelet aggregation in vitro]. Vlasova II; Torkhovskaia TI; Fortinskaia ES; Khalilov EM; Azizova OA Biull Eksp Biol Med; 1996 Feb; 121(2):199-203. PubMed ID: 9026131 [No Abstract] [Full Text] [Related]
12. Failure of two anti-platelet drugs (indobufen and dipyridamole) to improve thrombocytopenia in liver cirrhosis. Luzzatto G; Fabris F; Gerunda GE; Zangrandi F; Girolami A Acta Haematol; 1987; 77(2):101-6. PubMed ID: 2955629 [TBL] [Abstract][Full Text] [Related]
13. Preliminary studies on indobufen (K 3920). A new inhibitor of platelet aggregation. Gürsoy AZ; Yardimci TU; Emekli NB; Ugur MS; Ulutin ON Haematologica; 1981 Dec; 66(6):756-67. PubMed ID: 6802717 [No Abstract] [Full Text] [Related]
14. Platelet activation in patients with chronic pulmonary heart disease. Effect of dipyridamole treatment. Zhang X; Ling P Chin Med J (Engl); 1995 Feb; 108(2):95-7. PubMed ID: 7774397 [TBL] [Abstract][Full Text] [Related]
15. [The thromboxane-synthesis inhibitor Ibustrin in the treatment of diabetic angiopathies]. Shestakova MV; Vykhristiuk SG; Milen'kaia TM; Tokmakova AIu; Dedov II Ter Arkh; 1996; 68(10):18-22. PubMed ID: 9026936 [TBL] [Abstract][Full Text] [Related]
16. [Treatment with indobufen of platelet hyperaggregation in a group of patients with vascular diseases]. Barbieri U; Cappelli S; Zaniol P; Righi A; Artusi P; Scorrano M Minerva Med; 1991; 82(1-2):63-7. PubMed ID: 2000177 [TBL] [Abstract][Full Text] [Related]
17. Circulating platelet aggregates in cerebrovascular diseases. Preliminary data. Carrieri P; La Pia S; Indaco A; Pisano P; Orefice G; Iadevaia V Acta Neurol (Napoli); 1981 Jun; 3(3):500-4. PubMed ID: 7282470 [No Abstract] [Full Text] [Related]
18. Long-term trial (6 months) of the platelet aggregation inhibitory activity and biological safety of indobufen in cerebrovascular patients. Mansi D; Majello L; Palma V; De Michele G; Buscaino GA Acta Neurol (Napoli); 1983 Dec; 5(6):447-55. PubMed ID: 6367383 [No Abstract] [Full Text] [Related]
19. [Indobufen and calcium heparin for the prevention of thromboembolism in hip prosthesis surgery in patients who have undergone hemodilution]. Borghi B; Bugamelli S; deSimone N; Montebugnoli M; Ferrari S Minerva Anestesiol; 1990 Oct; 56(10):1117-20. PubMed ID: 2290518 [No Abstract] [Full Text] [Related]
20. [Clinical contribution to the study of indobufen, a new platelet aggregation inhibitor]. Ciammaichella A; Luzi M; Pezzi F; Recchia O Clin Ter; 1982 Aug; 102(4):387-95. PubMed ID: 6754219 [No Abstract] [Full Text] [Related] [Next] [New Search]